Ferric carboxymaltose
含有 Ferric carboxymaltose 的品牌、食物注意事项以及最重要的药物相互作用。
品牌
0未找到该活性成分的已注册品牌。
食物注意事项
0该活性成分暂无已收录的食物注意事项。
最重要的相互作用
前 10 项,共 50 项Ferric carboxymaltose 可能减少 3-Aza-2,3-Dihydrogeranyl Diphosphate 的吸收,从而可能导致血药浓度降低,并可能使疗效减弱。
专业视图
Ferric carboxymaltose can cause a decrease in the absorption of 3-Aza-2,3-Dihydrogeranyl Diphosphate resulting in a reduced serum concentration and potentially a decrease in efficacy.
Ferric carboxymaltose 可能减少 Carbidopa 的吸收,从而可能导致血药浓度降低,并可能使疗效减弱。
专业视图
Ferric carboxymaltose can cause a decrease in the absorption of Carbidopa resulting in a reduced serum concentration and potentially a decrease in efficacy.
Ferric carboxymaltose 可能减少 Cinoxacin 的吸收,从而可能导致血药浓度降低,并可能使疗效减弱。
专业视图
Ferric carboxymaltose can cause a decrease in the absorption of Cinoxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Ferric carboxymaltose 可能减少 Ciprofloxacin 的吸收,从而可能导致血药浓度降低,并可能使疗效减弱。
专业视图
Ferric carboxymaltose can cause a decrease in the absorption of Ciprofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
当 Deferiprone 与 Ferric carboxymaltose 联合使用时,Deferiprone 的血药浓度可能降低。
专业视图
The serum concentration of Deferiprone can be decreased when it is combined with Ferric carboxymaltose.
Dimercaprol 可能增强 Ferric carboxymaltose 的肾毒性作用。
专业视图
Dimercaprol may increase the nephrotoxic activities of Ferric carboxymaltose.
- Enoxacin中等
Ferric carboxymaltose 可能减少 Enoxacin 的吸收,从而可能导致血药浓度降低,并可能使疗效减弱。
专业视图
Ferric carboxymaltose can cause a decrease in the absorption of Enoxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Ferric carboxymaltose 可能减少 Calcium Phosphate 的吸收,从而可能导致血药浓度降低,并可能使疗效减弱。
专业视图
Ferric carboxymaltose can cause a decrease in the absorption of Calcium Phosphate resulting in a reduced serum concentration and potentially a decrease in efficacy.
Ferric carboxymaltose 可能减少 Calcium phosphate dihydrate 的吸收,从而可能导致血药浓度降低,并可能使疗效减弱。
专业视图
Ferric carboxymaltose can cause a decrease in the absorption of Calcium phosphate dihydrate resulting in a reduced serum concentration and potentially a decrease in efficacy.
Ferric carboxymaltose 可能减少 Delafloxacin 的吸收,从而可能导致血药浓度降低,并可能使疗效减弱。
专业视图
Ferric carboxymaltose can cause a decrease in the absorption of Delafloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.